Item 8.01. Other Events.
On September 10, 2009, representatives of AmerisourceBergen Corporation (the
"Registrant") will attend the Robert W. Baird & Company, Inc. 2009 Healthcare
Conference in New York. Speaking at the Conference will be Executive Vice
President and Chief Financial Officer Michael D. DiCandilo and Executive Vice
President and President AmerisourceBergen Drug Corporation Steven H. Collis. At
the Conference, Mr. DiCandilo intends to reaffirm the Registrant's fiscal year
2009 guidance. Accordingly, the Registrant continues to expect diluted earnings
per share from continuing operations for fiscal year 2009 to be at the higher
end of the range of $1.59 to $1.65, an increase of 10 percent to 15 percent over
the split-adjusted $1.44 in fiscal year 2008.
Add
ABC to Portfolio
Set Alert
Email to a
Friend